WebDisclosure WebDisclosure
Basculer en Français
11175 Companies
247024 Keywords
174892 Articles
133442 Press releases
Headlines Articles Press releases Somagenetix AG Remove
  1. Home
  2. Companies
  3. Somagenetix AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/08/2024 at 10:05, 2 years ago

    Somagenetix AG Secures CHF 10 Million to Advance Gene Therapy for CGD

    Series A Financing Gene Therapy Somagenetix AG Chronic Granulomatous Disease Vi Partners
  • BRIEF

    published on 10/08/2024 at 10:05, 2 years ago

    Somagenetix AG obtient 10 millions de francs suisses pour faire progresser la thérapie génique dans le traitement de la scoliose chronique

    Thérapie Génique Financement De Série A Somagenetix SA Maladie Granulomateuse Chronique Partenaires Vi
  • PRESS RELEASE

    published on 10/08/2024 at 10:00, 2 years ago

    Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD)

    Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD). Vi Partners leads the financing round alongside existing investors Schroders Capital, Zürcher Kantonalbank, and Verve Ventures
    Series A Financing Somagenetix AG Chronic Granulomatous Disease Vi Partners Lentiviral Gene Therapy
    Logo of Somagenetix AG
Accesswire
  • Published on 10/14/2026 at 23:55, 1 hour 32 minutes ago

    First Helium Announces Strategic Shallow Heavy Oil Acquisition

  • Published on 10/14/2026 at 23:45, 1 hour 42 minutes ago

    Polaris Renewable Energy Announces Q3 2026 Investor Call Details

  • Published on 10/14/2026 at 23:00, 2 hours 27 minutes ago

    Core Silver Completes Private Placement of $1.287M

  • Published on 10/14/2026 at 23:00, 2 hours 27 minutes ago

    ROK Resources Announces Return of Capital and Expanded 2026 Drilling Program

  • Published on 10/14/2026 at 23:00, 2 hours 27 minutes ago

    NXT Energy Solutions Provides Operational Update

View all ACCESSWIRE
EQS Group
  • Published on 10/15/2026 at 01:05, 22 minutes ago

    Opella: New study demonstrates successful cough treatment extends beyond symptom relief

  • Published on 10/14/2026 at 19:32, 5 hours 55 minutes ago

    EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2026: Earnings below prior year – net sales up – forecast confirmed

  • Published on 10/14/2026 at 19:05, 6 hours 22 minutes ago

    Bulgin Introduces 6000 Series Hybrid Buccaneer Connectors for Power and Signal Connectivity

  • Published on 10/14/2026 at 19:00, 6 hours 27 minutes ago

    Informations relatives à l’augmentation de capital

  • Published on 10/14/2026 at 18:48, 6 hours 39 minutes ago

    Holding(s) in Company

View all EQS
Les Echos
  • Published on 10/14/2026 at 18:00, 7 hours 27 minutes ago

    CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.

  • Published on 10/14/2026 at 18:00, 7 hours 27 minutes ago

    CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.

  • Published on 10/14/2026 at 17:45, 7 hours 42 minutes ago

    Mint : Résultats semestriels 2026.

  • Published on 10/14/2026 at 17:40, 7 hours 47 minutes ago

    Mersen obtient la certification internationale Living Wage pour son engagement en faveur du bien-être de ses collaborateurs

  • Published on 10/14/2026 at 17:40, 7 hours 47 minutes ago

    Mersen’s commitment to employee well-being earns it international Living Wage certification

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy